Solventum CorporationSOLV
NYSE•Healthcare•Medical Instruments & Supplies
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $8.26B, declining 0.6% year-over-year. TTM net income stood at $1.43B (277.8% growth). Quarterly EBITDA was $216.00M and operating income was $81.00M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze SOLV growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters